Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
about
Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?Lessons learned from gene transfer approachesElimination of rheumatoid synovium in situ using a Fas ligand 'gene scalpel'Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclastsUse of Lentiviral Particles As a Cell Membrane-Based mFasL Delivery System for In Vivo Treatment of Inflammatory Arthritis.BH3-only proteins in rheumatoid arthritis: potential targets for therapeutic intervention.Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilegeApoptosis and its clinical impact.Monoclonal antibodies and other biologic therapies.New therapies in development for autoimmune diseases: their rationale for combination treatment.Transgenic expression in mouse lung reveals distinct biological roles for the adenovirus type 5 E1A 243- and 289-amino-acid proteinsEndogenous regulation of a therapeutic transgene restores homeostasis in arthritic joints.Gene therapy in nonhuman primate models of human autoimmune disease.Gene therapy for arthritis.Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancerHarnessing programmed cell death as a therapeutic strategy in rheumatic diseases.Fas (CD95)-related apoptosis and rheumatoid arthritis.Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosisPro-apoptotic Bid is required for the resolution of the effector phase of inflammatory arthritis.Adenoviral-mediated gene transfer in lymphocytes.MHC-dependent desensitization of intrinsic anti-self reactivity.Proinflammatory consequences of transgenic fas ligand expression in the heart.The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.Cell death-independent activities of the death receptors CD95, TRAILR1, and TRAILR2.Fas counterattack in cholangiocarcinoma: a mechanism for immune evasion in human hilar cholangiocarcinomas.Apoptosis in Porphyromonas gingivalis-specific T-cell lines.Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous fas ligand protein.Modulation of collagen-induced arthritis by adenovirus-mediated intra-articular expression of modified collagen type II.Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p21(Cip1) gene into the joints.Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis.Recombinant adeno-associated virus preferentially transduces human, compared to mouse, synovium: implications for arthritis therapy.Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis.Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis.Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients.Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity.Fas ligand gene-carrying adeno-5 AdEasy viruses can be efficiently propagated in apoptosis-sensitive human embryonic retinoblast 911 cells.The contralateral effect conferred by intra-articular adenovirus-mediated gene transfer of viral IL-10 is specific to the immunizing antigen.Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection.Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer.
P2860
Q24796801-CC01CB9C-9BDF-4B66-B046-E78F61327772Q24804941-156C8D45-C899-4A07-BBF6-0D77FD4314F0Q24812727-A929028C-1B16-4459-AEA0-2B888CAF3573Q28583027-8EC08B49-9A01-4739-9358-EC8AED788662Q33586182-50909960-9C59-4474-8C9C-E2D15539ED29Q33727248-7478ED9D-5561-410F-92AF-D811EEA2F0AAQ33997713-7413A2C3-4D54-4D1B-86EB-39A7F95E0A1EQ34214558-065342D4-C4BB-4CD6-BC6F-9C84113CEF36Q34227074-75347FBE-C692-4D1D-95D8-82F1545991A1Q34309745-2A24E71A-2BAD-45F5-AC02-12DDE52B36B1Q34362230-186B543C-9C69-4CA8-AEC5-A23063D5AFC0Q34791340-FB1A644E-23A2-44B9-A3E2-8BABB1A386EAQ35122173-C8D6B5FE-9E77-4773-84AA-D100D00A3DFBQ35122176-84749146-AB7F-4AE2-A9DF-69210A67E8D6Q35354010-B13535BC-D2CC-483D-97CD-C2DBED911336Q36219516-D906F5D2-C9FC-4E1E-B6F6-C685FCAD37CDQ36256257-576A0EDC-5879-4545-AEED-E5F02302CC44Q36368539-FC96AFC5-BDB6-45D8-A780-5F6390641253Q36375186-4623F262-EB73-4FDA-AE1F-004E208D01EDQ36392288-94DF4AA1-FF70-4017-A634-27FE0F2D4F66Q36641367-E4A51770-1A2E-4130-90C4-638C097361A1Q36978119-5406C5A9-A364-4596-A144-AD692ACD5DE4Q37194997-88949286-7A6B-437E-B764-6CDA966C3787Q37852758-D02C3C7B-FE61-4492-B6D9-EE03E85DB384Q39013916-58F8D077-5117-48DF-B730-8CEB434FB2A5Q40749615-8606C844-625A-4CE6-9495-E54E5D440758Q40868434-88999973-AD6E-41E2-8475-B2BABD17E86BQ41351550-0BEB41CC-709B-42AC-997D-AC6EAE0C59B5Q42131492-C4A2BAA3-29FB-4880-87A7-AE172FFD80A5Q43655450-8B9D987D-6F92-4C22-A114-E50D5813CB62Q44017553-6960028C-44A6-4F86-B075-9808F81F3A16Q45411417-FE6EF0CB-2BBD-477F-8FAD-40CF06623EDDQ45739253-4EF70D29-F38F-42F0-8A52-C71F455A12B7Q45859175-8FA2355C-E1F6-47CE-891C-AED338149E24Q45862110-8B074294-0CDE-4E49-8630-C318486D2231Q45864635-31FA6974-3A71-4AD3-BF02-686557F661D3Q45865361-F45DBBF6-F357-4174-B317-337D9433CADEQ45869577-6F0AD383-FFDC-4D15-9523-3248F90695DDQ45880270-8BD6B7DB-B097-4C5A-ADDB-18FC5D9F0F25Q45880272-5EB6DCA7-7FBA-42A1-9709-16DD9EA521AB
P2860
Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
@en
Amelioration of collagen-induced arthritis by CD95
@nl
type
label
Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
@en
Amelioration of collagen-induced arthritis by CD95
@nl
prefLabel
Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
@en
Amelioration of collagen-induced arthritis by CD95
@nl
P2093
P2860
P356
P1476
Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer
@en
P2093
Samoilova EB
P2860
P304
P356
10.1172/JCI119726
P407
P577
1997-10-01T00:00:00Z